Arnold Lippa

Arnold S.
Lippa was the founder of Patch International, Inc. (1984), serving as President & Chief Operating Officer from 1984 to 1994.
Dr. Lippa was the founder of DOV Pharmaceutical, Inc. (1995), serving as Director from 2005 to 2006.
Dr. Lippa is the founder of Atypical BioVentures Fund, LLC (2004), serving as Manager since 2004.
Dr. Lippa is the founder of Atypical BioCapital Management LLC (2004), serving as Manager since 2004.
Dr. Lippa is the founder of T.
Morgen Capital LLC (2005), serving as Senior Managing Director since 2005.
Dr. Lippa is the founder of Xintria Pharmaceutical Corp.
(2006), serving as Executive Chairman since 2015.
Current jobs include Executive Chairman, President & CEO at RespireRx Pharmaceuticals, Inc. since 2022, and President at Aurora Capital LLC since 2005.
Former jobs include Director-Molecular Neurobiology at Wyeth Holdings LLC, Independent Director at Hepion Pharmaceuticals, Inc. from 2015 to 2023, Professor at City University of New York, and Professor at New York University School of Medicine.